IMMUNE FUNCTION PARAMETERS AT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - CORRELATION WITH THE FAB CLASSIFICATION AND PROGNOSIS

被引:0
|
作者
SYMEONIDIS, A
KOURAKLI, A
KATEVAS, P
PERRAKI, M
TINIAKOU, M
MATSOUKA, P
GEORGOULIAS, V
ZOUMBOS, N
机构
[1] UNIV PATRAS,SCH MED,DEPT INTERNAL MED,DIV HAEMATOL,BOX 1045,GR-26110 PATRAS,GREECE
[2] UNIV PATRAS,IMMUNOHAEMATOL LAB,PATRAS,GREECE
关键词
MYELODYSPLASIA; IMMUNE ABNORMALITIES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined nine immune function parameters at diagnosis in patients with myelodysplastic syndromes (MDS) and correlated the results with the FAB classification and prognosis by univariate and multivariate analyses. Patients with refractory anaemia (RA) and refractory anaemia with ring sideroblasts (RAS) tended to have a higher CD4/CD8 ratio and a lower amount of gamma-globulins and soluble interleukin-2 receptors in serum in comparison to those suffering from the other three subgroups of MDS. FAB classification, neutrophil and CD8+ T-cell number had the best discriminatory capacity for predicting survival less than 1 year, and FAB classification, neutrophil number and serum TNF levels were predictors for conversion to acute leukaemia. The frequent occurrence of infections, on the other hand, could be better predicted by the absolute numbers of neutrophils and CD4+ cells and by the skin test score.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 50 条
  • [1] Myelodysplastic syndromes: Histopathologic data and correlation with FAB classification.
    Romeo, M
    Chauffaille, MLF
    Silva, MRR
    Kerbauy, J
    BLOOD, 1998, 92 (10) : 254B - 254B
  • [2] Beyond the FAB classification for myelodysplastic syndromes
    不详
    HAEMATOLOGICA, 1999, 84 (01) : 1 - 2
  • [3] FAB CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES - MERITS AND CONTROVERSIES
    VERHOEF, GEG
    PITTALUGA, S
    DEWOLFPEETERS, C
    BOOGAERTS, MA
    ANNALS OF HEMATOLOGY, 1995, 71 (01) : 3 - 11
  • [4] FAB CLASSIFICATION AND PROGNOSIS OF MYELODYSPLASTIC SYNDROME (MDS)
    KRIEGER, O
    NOWOTNY, H
    LUTZ, D
    BLUT, 1984, 49 (03): : 246 - 246
  • [5] Diagnosis and classification of myelodysplastic syndromes
    Hasserjian, Robert P.
    Germing, Ulrich
    Malcovati, Luca
    BLOOD, 2023, 142 (26) : 2247 - 2257
  • [6] The FAB classification of the myelodysplastic syndromes: The impact of the WHO proposals
    Bennett, JM
    LEUKEMIA, 2000, 14 (05) : 960 - 960
  • [7] PROGNOSTIC VALUE OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    AUL, C
    FISCHER, JT
    HORSTKOTTE, D
    SCHNEIDER, W
    BLUT, 1984, 49 (03): : 246 - 246
  • [8] Correlation Between Dysplastic Lineage and Type of Cytopenia in Myelodysplastic Syndromes Patients With Refractory Anemia According to the FAB Classification
    Matsuda, Akira
    Jinnai, Itsuro
    Iwanaga, Masako
    Okamura, Daisuke
    Ishikawa, Maho
    Maeda, Tomoya
    Hata, Tomoko
    Kawai, Nobutaka
    Miyazaki, Yasushi
    Bessho, Masami
    Tomonaga, Masao
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (02) : 253 - 257
  • [9] The myelodysplastic syndromes: diagnosis, prognosis and therapy
    Clissa, Cristina
    Finelli, Carlo
    de Vivo, Antonio
    ITALIAN JOURNAL OF MEDICINE, 2011, 5 (02) : 90 - 97
  • [10] Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment
    Germing, Ulrich
    Kobbe, Guido
    Haas, Rainer
    Gattermann, Norbert
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (46): : 783 - +